<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Natale, Andrea</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Novel Contact Force Catheters are Effective and Safe for Paroxysmal AF Ablation</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses the 12-month findings from the Comparison of Pulmonary Vein Isolation Using SmartTouch Catheter With or Without Real-Time Contact Force Data trial [SMART; NCT01730924]. The study met its safety and effectiveness endpoints with no unanticipated device-related adverse events, and with 72% of the ablated patients free from atrial fibrillation recurrence. Furthermore, increased freedom from arrhythmia was correlated with increased percentage of time within physician-targeted contact force range.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>